Study Stopped
Only 4 participants completed due to COVID-19 and the many lockdowns. We received a NIH R21 to complete a larger version of this trial and are working on launching this larger trial and submitting it to ClinicalTrials.gov.
Influence of Exercise on the Gut Microbiome of Overweight and Obese Adults With Prediabetes
1 other identifier
interventional
4
1 country
1
Brief Summary
Purpose: The investigators propose a 20-participant randomized 2-arm parallel trial with a delayed-intervention control examining how 8 weeks of moderate-intensity walking exercise alters the gut microbiome, short chain fatty acid (SCFA)-producing taxa, and the cardiometabolic profile and body weight of individuals who are overweight or obese and have prediabetes (PreD). Aim 1: Examine and compare exercise-related shifts in the gut microbiome of individuals with PreD. Aim 2: Examine and compare exercise-related changes in SCFA-producing taxa. Exploratory Aim: Examine what percentage of the exercise-related changes observed in participants' gut microbiome and SCFA-producing taxa mediate changes in their cardiometabolic profile and body weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2019
CompletedFirst Posted
Study publicly available on registry
October 11, 2019
CompletedStudy Start
First participant enrolled
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedJuly 13, 2021
July 1, 2021
7 months
October 10, 2019
July 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Shannon Index (Alpha-Diversity) as Reflected in Change in Operational Taxonomic Units
Alpha diversity is the mean species diversity of a local site, which, in this study, is the fecal sample provided by participants used as a proxy for sampling the gut microbiome. The Shannon Index is based on the weighted geometric mean of the proportional abundances of the types of microbes. Change in alpha diversity will be reported as change in operational taxonomic units (OTUs).
Baseline, 8 weeks
Secondary Outcomes (11)
Change in Plasma LDL Concentrations
Baseline, 8 weeks
Change in Plasma HDL Concentrations
Baseline, 8 weeks
Change in Plasma Total Cholesterol Concentrations
Baseline, 8 weeks
Change in Plasma Insulin Concentrations
Baseline, 8 weeks
Change in Plasma Glucose Concentrations
Baseline, 8 weeks
- +6 more secondary outcomes
Study Arms (2)
Immediate Experimental Group
EXPERIMENTALParticipants will immediately begin an experimental supervised moderate-intensity treadmill walking intervention program.
Delayed Intervention Control Group
NO INTERVENTIONParticipants will be asked to maintain their usual physical activity during the initial 8-week intervention period but will undergo all data collection procedures. Following the initial intervention period, these participants will be given the option to complete the 8-week intervention, with identical data collection procedures employed.
Interventions
Participants will attend 3 treadmill walking sessions/week for 8 weeks (24 total)-exercising at 60-75% of their heart rate (HR) reserve monitored using Polar FT1 HR monitors. All walking sessions will take place using treadmills within the West Bank Office Building on the UMN-Twin Cities campus. Each walking session will be 30 min long during intervention weeks 1-4 and 45 min each during weeks 5-8. This exercise dose is equivalent to that employed in the only two human studies of exercise and the gut microbiome in addition to the dosage observed necessary to yield meaningful cardiometabolic changes. After the 4th- and 8th-weeks of the intervention, participants in both study groups will again undergo outcome assessments
Eligibility Criteria
You may qualify if:
- Classified as overweight or obese with BMI 25.0-39.9 kg/m2
- Diagnosis of prediabetes as classified by a fasted blood glucose of 100 - 125 mg/dL, 2-hour oral glucose tolerance test of 140 - 199 mg/dL, or HbA1C level of 5.7% - 6.5%
- Currently engaged in \< 150 minutes/week of physical activity-confirmed via the Modifiable Activity Questionnaire
You may not qualify if:
- Individuals with contraindications to exercise participation as assessed by the Physical Activity Readiness Questionnaire
- Self-reported physical/mental disabilities or gastrointestinal conditions
- Antibiotic usage within the last 45 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Epidemiology Clinical Research Center
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2019
First Posted
October 11, 2019
Study Start
February 10, 2020
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
July 13, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share